Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Trial Identifier: D6402C00003
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04798222
Start Date: June 2021
Primary Completion Date: September 2021
Study Completion Date: September 2021
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation

Trial Locations